PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

NCT06336239 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Anzhen Hospital

Phase

Observational

Started

2023-12-21

Last updated

2024-09-19

Condition(s) studied

Cardiovascular DiseaseType 2 Diabetes Mellitus

Study summary

The association between Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) is well established. Traditional risk factors for CVD and CKD are similar, with type 2 diabetes mellitus (T2DM) being the most prevalent risk factor. However, CKD is underdiagnosed and undertreated in patients with CVD. Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups, reduce adverse events in CVD patients, and prevent progression of CKD to End Stage Renal Disease (ESRD).

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Age ≥18 years old; * Diagnosed T2DM combined with ≥1 CVD (hypertension, coronary heart disease, atrial fibrillation, heart failure); * During the data collection period, they went to the outpatient clinic of the cardiology department of the research center, or received treatment in the cardiology department; * Ability to self-sign informed consent (electronic /paper). Exclusion Criteria: * Pregnant or lactating women; * Dialysis patients; * Other diseases that lead to elevated albuminuria, such as severe infection, confirmed primary glomerular disease, etc.; . Malignant tumors being treated (surgery, chemotherapy, radiotherapy or targeted therapy); * Cachexia (CSS score ≥ 5 points); * Severe liver disease (Child- Pugh grade C) ; * Participated in an interventional clinical trial in the past three months.

Primary outcome measure(s)

The prevalence of albuminuria — On the day of patients enrollment.
To assess the prevalence of albuminuria in patients who are combined with type 2 diabetes mellitus and different cardiovascular diseases in inpatient and outpatient cardiology departments of secondary and tertiary hospitals in China.

Trial sites (27)

Facility	City	Region	Status
Beijing Sixth Hospital	Beijing	Beijing Municipality	Recruiting
Fangshan District First Hospital	Beijing	Beijing Municipality	Completed
Peking University Third Hospital	Beijing	Beijing Municipality	Completed
Chinese PLA Army Characteristic Medical Center	Chongqing	Chongqing Municipality	Completed
Haidong City Second People's Hospital	Haidong	Gansu	Not Yet Recruiting
The First Affiliated Hospital of Sun Yat-sen University	Guangzhou	Guangdong	Not Yet Recruiting
First Hospital of Hebei Medical University	Shijiazhuang	Hebei	Recruiting
Ruyang County People's Hospita	Luoyang	Henan	Recruiting
Luoyang Sixth People's Hospita	Luoyang	Henan	Completed
Yongcheng People's Hospital	Yongcheng	Henan	Completed
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	Henan	Not Yet Recruiting
Zhangjiagang Sixth People's Hospital	Zhangjiagang	Jiangsu	Completed
Shenyang Ninth People's Hospital	Shenyang	Liaoning	Recruiting
Shenyang Tenth People's Hospital	Shenyang	Liaoning	Active Not Recruiting
Jining First People's Hospital	Jining	Shandong	Not Yet Recruiting
Tai'an First People's Hospital	Tai’an	Shandong	Completed
Weihai Central Hospital	Weihai	Shandong	Not Yet Recruiting
Jing'an District Central Hospital of Shanghai	Shanghai	Shanghai Municipality	Completed
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine	Shanghai	Shanghai Municipality	Not Yet Recruiting
Zhongshan Hospital Fudan University Qingpu Branch	Shanghai	Shanghai Municipality	Recruiting
Qinyuan County People's Hospital	Changzhi	Shanxi	Completed
Shanxi Bethune Hospital	Taiyuan	Shanxi	Recruiting
The First Affiliated Hospital of Xi'an Jiaotong University	XI Ail	Shanxi	Not Yet Recruiting
The Fifth People's Hospital of Sichuan Province	Chengdu	Sichuan	Not Yet Recruiting
West China Hospital of Sichuan University	Chengdu	Sichuan	Recruiting
The First Affiliated Hospital of Xinjiang Medical University	Ürümqi	Xinjiang	Not Yet Recruiting
Taizhou Central Hospital	Taizhou	Zhejiang	Recruiting

More Beijing Anzhen Hospital trials in China

AI-Based Risk Factor Analysis and Prediction Model of MACE in Elderly Hip Fracture Patients Postoperatively Active, not recruiting

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention Recruiting

Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke Recruiting

CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery. Starting soon

Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly Recruiting

Other trials for the same condition

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS) Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin Recruiting

Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls Recruiting

Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial Starting soon

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06336239 on ClinicalTrials.gov ↗ ← All trials in China